Company Filing History:
Years Active: 2018
Title: Mark Ormiston: Innovator in Cellular Reprogramming
Introduction
Mark Ormiston is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of cellular reprogramming, particularly through his innovative patent. His work focuses on advancing medical science and improving patient care.
Latest Patents
Mark Ormiston holds a patent for a "Cellular substrate for nuclear reprogramming." This invention relates to the use of late out-growth endothelial progenitor cells (L-EPCs) as a cellular substrate for the generation of Induced pluripotent stem cells (iPSCs). This technology may be instrumental in producing patient-specific tissues for various applications, including disease modeling, drug and toxicology screening, tissue replacement, and the delivery of gene therapy. He has 1 patent to his name.
Career Highlights
Mark Ormiston is associated with Cambridge Enterprise Limited, where he continues to work on innovative projects that push the boundaries of medical research. His career is marked by a commitment to developing technologies that can transform healthcare.
Collaborations
Throughout his career, Mark has collaborated with esteemed colleagues, including Nicholas W Morrell and Amer Rana. These partnerships have fostered an environment of innovation and have contributed to the advancement of his research.
Conclusion
Mark Ormiston's work in cellular reprogramming exemplifies the potential of innovative technologies in medicine. His contributions are paving the way for future advancements in patient-specific treatments and therapies.